This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignees: Cancer Research Technology Limited, Iceni Diagnostics Limited, Other. Active years: 2003-2019.
Company Filing History:
1 out of 268 
1 out of 1 
1 out of 834,453 Years Active: 2003-2019
Title: David Andrew Russell: Innovator in Nanoparticle Technology
Introduction
David Andrew Russell is a notable inventor based in Norfolk, GB. He has made significant contributions to the field of nanoparticle technology, particularly in the detection of viruses and the development of functionalized nanoparticles. With a total of 3 patents, his work has the potential to impact various medical applications.
Latest Patents
One of Russell's latest patents focuses on virus detection. This invention provides methods and materials for detecting influenza viruses using a nanoparticle probe that comprises a plurality of glycoconjugate ligands. Each ligand has multiple sialic-acid containing recognition groups that specifically bind to the hemagglutinin on the target influenza virus. The binding of these probes is detected by a plasmonic signal that is specific to the influenza virus.
Another significant patent involves photosensitizer functionalized nanoparticles. This invention relates to the self-assembly of a photosensitizer on a nanoparticle and provides methods for producing stabilized nanoparticles. These nanoparticles can be utilized in Photodynamic Therapy (PDT), showcasing the versatility and potential of Russell's innovations in medical treatments.
Career Highlights
Throughout his career, David Andrew Russell has worked with various companies, including Iceni Diagnostics Limited. His expertise in nanoparticle technology has positioned him as a key figure in the field, contributing to advancements that may lead to improved diagnostic and therapeutic methods.
Collaborations
Russell has collaborated with notable individuals in his field, including William Guy Love and Michael J Cook. These partnerships have likely enhanced the scope and impact of his inventions.
Conclusion
David Andrew Russell's innovative work in nanoparticle technology demonstrates his commitment to advancing medical science. His patents in virus detection and functionalized nanoparticles highlight the potential for significant contributions to healthcare.